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Redressing the Unconscionable Health Gap:
A Global Plan for Justice
Lawrence O. Gostin*
Consider two children—one born in sub-Saharan Africa and the other
in the United States.  The African child is twenty-five times more likely to
die in the first five years of life;1 if she lives to child-bearing age, she is a
two hundred times more likely to die in labor;2 and overall, she will die
thirty years earlier than the American child.3  The global health gap between
rich and poor is vast: “in one year alone, fourteen million of the poorest
people in the world died [prematurely], while only four million would have
died if this population had the same death rate as the global rich.”4
The international community is well aware of such glaring health ine-
qualities, but it is deeply resistant to taking bold remedial action.  Interna-
tional development organizations appear much more concerned with the
geostrategic and philanthropic interests of donors than the health needs of
the poor.  The scale of foreign aid is both insufficient and unsustainable and
fails to address the key determinants of health.  As a result, the world’s dis-
tribution of the “good” of human health remains fundamentally unfair, caus-
ing enormous physical and mental suffering by those who experience the
compounding disadvantages of poverty and ill health.
If the health gap is unfair and unacceptable, then how can the interna-
tional community be galvanized to make a genuine difference?  In this Arti-
* Linda D. and Timothy J. O’Neill Professor of Global Health Law and Faculty Director of
the O’Neill Institute for National and Global Health Law at the Georgetown University Law
Center; Professor of Public Health, The Johns Hopkins University; and Visiting Professor,
Oxford University.  This Article is based on the keynote address presented by Professor Gostin
at the International Conference on Realising Rights to Health and Development for All, Hanoi,
Viet Nam, October 28–29, 2009. See International Conference on Realising Rights to Health
and Development for All, http://www.healthandrights.com/ (on file with the Harvard Law
School Library); Helen Clark, ‘ODA Is What Governments Want to Do at Their Whim’, INTER
PRESS SERV., Nov. 5, 2009, http://www.ipsnews.net/news.asp?idnews=49143 (on file with the
Harvard Law School Library). Professor Gostin expresses his gratitude to HLPR editors Isley
Markman and Samantha Hong for exceptional assistance.
1 UNITED NATIONS CHILDREN’S FUND [ UNICEF],  THE STATE OF THE WORLD’S CHILDREN
2007, at 105 (2006), available at http://www.unicef.org/sowc07/docs/sowc07.pdf.
2 UNICEF, PROGRESS FOR CHILDREN: A REPORT CARD ON MATERNAL MORTALITY 44
(2008), available at http://www.childinfo.org/files/progress_for_children_maternalmortality.
pdf.
3 UNICEF, supra note 1; see generally COMM’N ON SOC. DETERMINANTS OF HEALTH,
WORLD HEALTH ORG. [WHO], CLOSING THE GAP IN A GENERATION: HEALTH EQUITY
THROUGH ACTION ON THE SOCIAL DETERMINANTS OF HEALTH (2008), available at http://
whqlibdoc.who.int/publications/2008/9789241563703_eng.pdf; J. P. Ruger & H-J Kim,
Global Health Inequalities: An International Comparison, 60 J. EPIDEMIOLOGY & COMMUNITY
HEALTH 928 (2006).
4 Lawrence O. Gostin, Meeting Basic Survival Needs of the World’s Least Healthy People,
96 GEO. L.J. 331, 337 (2008) (citing DAVIDSON R. GWATKIN & MICHEL GUILLOT, WORLD
BANK, THE BURDEN OF DISEASE AMONG THE GLOBAL POOR 19–20 (2000)).
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cle, I propose an international call to action through the adoption of a Global
Plan for Justice—a voluntary compact among states and their partners in
business, philanthropy, and civil society to redress health inequalities.
The Global Plan for Justice would be a form of “soft” norm setting,
rather than a legally binding treaty.  It could be achieved relatively easily
with the passage of a World Health Assembly resolution.  In the resolution,
member states would authorize the World Health Organization (WHO) Di-
rector General—in collaboration with state and nonstate actors—to establish
a Global Plan for Justice.  The Director General would negotiate funding
commitments, spending priorities, an allocation system, and mechanisms for
monitoring, compliance, and implementation.  The Global Plan for Justice
would not require states to acquiesce to a treaty or to establish a new organi-
zation or governance structure.  Rather, it would encourage the WHO to ex-
ercise its constitutional powers to set norms, exercise leadership, and
coordinate activities on the principal dimensions of world health.
Under the Global Plan for Justice, states would devote resources to a
Global Health Fund based on their ability to pay—for example, 0.25% of
Gross National Income (GNI) per annum—in addition to maintaining cur-
rent development assistance devoted to programs and activities of their
choice.  Global Health Fund resources would be allocated based on the
health needs of developing countries measured by poverty, morbidity, and
premature mortality.
The core missions of the Global Plan for Justice would be to (1) ensure
the fair allocation of essential vaccines and medicines, with particular atten-
tion to low- and middle-income countries in a public health emergency; (2)
meet basic survival needs and create the conditions in which people can be
healthy; and (3) help countries that will suffer most to adapt to the health
impacts of climate change.
The Global Plan for Justice differs in scale from my more ambitious
proposal for a Framework Convention on Global Health.5  The Framework
Convention offers a broadly imagined global health governance system for
coordinating actors, setting funding levels and priorities and harnessing the
creativity of nonstate actors.  However, the negotiation of a multilateral
treaty involving resource distribution from rich to poor states would face
political obstacles that limit its prospects of success.  Because the Global
Plan for Justice described in this Article is a voluntary compact and does not
create binding legal obligations, it is more likely to gain international
acceptance.
Skeptics may counter that a voluntary compact will be less effective in
holding powerful states accountable.  However, world health—unlike world
trade—has never developed mechanisms for adjudication and enforcement,
and it is unlikely to do so in the near term.  The trade off between a binding
and a voluntary compact may be worthwhile because soft norms can still,
over time, alter state action.  To ensure progress, it will be necessary first to
5 See generally id.
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persuade states to assume obligations voluntarily with soft targets and en-
forcement.  Binding international obligations of justice in health must be
built over time.
Part I of this Article sets out the Plan’s governance structure and de-
scribes the problems with current global coordination.  Part II sets out the
Plan’s funding and critiques past donor-driven funding models.  And Part III
sets out the Plan’s priorities, describing the problems with current prioritiza-
tion of high profile health hazards.  In each Part, I explain why extant global
health governance is destined to fail and will never meaningfully close the
health gap.  Changing the paradigm to harmonize fragmented activities, en-
sure stable funding, and set priorities could dramatically transform prospects
for good health among the world’s poorest populations.
I. GOVERNANCE: COORDINATING FRAGMENTED GLOBAL
HEALTH ACTIVITIES
Despite the importance of a coherent strategy for global health, the
traditional system of global health governance has been unable to effectively
manage the vast proliferation of new actors.  The deluge of actors and initia-
tives, often focused on specific diseases, includes more than forty bilateral
donors, twenty-six UN agencies, twenty global and regional funds, and
ninety global health initiatives,6 not to mention the explosion of aid organi-
zations, religious missions, and volunteers operating on the ground.7  This
increasingly crowded landscape of health programs and funding sources has
resulted in rampant fragmentation, duplication, and confusion.  Fragmenta-
tion can have crippling effects at the national level, where developing coun-
tries “face a bewildering array of global agencies from which to elicit
support.”8  Consequently health ministries are overburdened with “writing
proposals and reports for donors whose interests, activities, and processes
sometimes overlap, but often differ.”9
Other problems arise out of the growing competition between interna-
tional nongovernmental organizations (NGOs) and local service providers
(for example, governments, businesses, and community-based organizations)
for funding and human resources.10  The encroachment of international ac-
tors on capable local actors hinders efforts toward greater country accounta-
bility and control.  When well-funded NGOs create state-of-the-art AIDS
clinics, for example, they are able to offer far more lucrative salaries and
6 See Karen McColl, Europe Told to Deliver More Aid for Health, 371 LANCET 2072,
2072 (2008).
7 See Michael Marmot, Working Through the Issues of Global Governance for Health, 374
LANCET 1231, 1231 (2009) (more than 37,000 international nongovernmental organizations
work in health and development).
8 David E. Bloom, Governing Global Health, 44 FIN. & DEV. 31, 33 (2007), available at
http://www.imf.org/external/pubs/ft/fandd/2007/12/pdf/bloom.pdf.
9 Id.
10 See Laurie Garrett, The Challenge of Global Health, 86 FOREIGN AFF. 14, 30 (2007).
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better working conditions than local providers.  This can drain public or pri-
vate initiatives in the host country, making it even more difficult to provide
sustainable services.
Several recent efforts at coordination and harmonization have been
launched, such as the Health 8 (H8) and the International Health Partnership
(IHP), but they have had limited impact.11  Led by a handful of powerful
elites, the H8 and IHP discuss common agendas but do not harmonize them.
They exclude the perspectives of many smaller nongovernmental actors and
developing countries.
The Plan’s Architecture
The Global Plan for Justice would be administered by the World Health
Organization (WHO).  Under the Plan, the WHO would have the duty to
coordinate currently fragmented global health activities.  It would provide a
structured forum for all stakeholders, establish effective norms, recommend
pathways for cooperative action, and monitor and evaluate compliance.  By
administering the Global Plan for Justice, the WHO would solidify its in-
tended status as the global health leader.
Critics may question why the Global Plan for Justice places governance
responsibilities with the WHO.  It is true that the WHO Constitution estab-
lishes a broad mission to attain “the highest possible level of health,”
designates the agency as the “directing and coordinating authority on inter-
national health work,” and charges the Director General with establishing
and maintaining “effective collaboration” with a broad range of actors in-
cluding intergovernmental organizations, states, and the scientific commu-
nity.12  But prominent scholars have strongly criticized the WHO for its
reluctance to lead despite its bold constitutional mission and powers.13  At
the turn of the twenty-first century, more than sixty years after its founding,
the WHO has lost the confidence of the international community, which in
recent years has often turned away from the WHO and toward newly created
health institutions, such as the Global Fund to Fight AIDS, Tuberculosis, and
Malaria.
Although the WHO faces sharp criticism for its failure to exercise its
normative powers, it is the only organization with the mandate and inclusive
constituency to lead a major global health initiative.  If a new institution
were created out of whole cloth for such a global health project, it would
11 See Christopher J. L. Murray et al., The Global Campaign for the Health MDGs: Chal-
lenges, Opportunities, and the Imperative of Shared Learning, 370 LANCET 1018, 1019 (2007).
12 Constitution of the World Health Organization, art. 1, 2, §§ a, b, July 22, 1946, 62 Stat.
2679, 14 U.N.T.S. 185, available at http://www.who.int/governance/eb/who_constitution_en.
pdf.
13 See generally David P. Fidler, The Future of the World Health Organization: What Role
for International Law?, 31 VAND. J. TRANSNAT’L L. 1079 (1998); Allyn Lise Taylor, Making
the World Health Organization Work: A Legal Framework for Universal Access to the Condi-
tions for Health, 18 AM. J.L. & MED. 301 (1992).
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severely undermine the WHO.  Thus, rather than creating another global
health governance structure with high opportunity costs, the Global Plan for
Justice aims to bolster the power and legitimacy of the WHO.  Among all
other alternatives, the agency is in the best position to harmonize the activi-
ties of state and nonstate actors.
II. FUNDING: SUSTAINABLE AND SCALABLE RESOURCES FOR
GLOBAL HEALTH
Perhaps the most important goal for global health governance is to en-
sure that international funding is adequate, predictable, and scalable to
needs.  Obstacles at both the international and national levels currently
thwart this goal.  At the international level, the WHO is highly dependent on
member states for financial resources to carry out its constitutionally man-
dated functions.  As a result, the agency is chronically under-resourced, with
funding increasingly devoted to special projects that are favored by donors
but do not reflect actual global burdens of injury and disease.14
At the national level, developing countries desperately need funding to
build capacity, yet funding is sporadic and subject to the political discretion
of donors.  From year to year, donors may increase or decrease funding,
initiate new programs or discontinue existing programs, or place restrictive
conditions on the use of resources.  In this unpredictable environment, min-
istries of health cannot build infrastructure, operate programs, or sensibly
plan for the long term.  What developing countries need are stable and pre-
dictable sources of funding, with discretion to spend on local priorities.15
A problem with current funding approaches is that there is no method
of holding rich states accountable for providing sufficient and stable interna-
tional health assistance to states that lack the capacity to provide for them-
selves.  Certainly, states and philanthropists have significantly increased
global health funding, which rose to $21.8 billion in 2007.16  This level of
financial assistance may appear substantial, but it remains modest in com-
parison to the annual $1.5 trillion spent globally on military expenditures
(2.4% of global GDP),17 and the $265 billion spent on agricultural
subsides.18
14 See David Stuckler et al., WHO’s Budgetary Allocations and Burden of Disease: A
Comparative Analysis, 372 LANCET 1563, 1563 (2008).
15 See Devi Sridhar, Seven Challenges in International Development Assistance for
Health, J.L. MED. & ETHICS (forthcoming 2010) (summary available at http://www.global
economicgovernance.org/wp-content/uploads/Sridhar-Seven-Challenges-in-International-De-
velopment-Assistance-for-Health.pdf).
16 Nirmala Ravishankar et al., Financing of Global Health: Tracking Development Assis-
tance for Health From 1990 to 2007, 373 LANCET 2113, 2113 (2009).
17 World Bank, Military Expenditure (% of GDP), http://datafinder.worldbank.org/mili-
tary-expenditure?cid=GPD_42 (on file with the Harvard Law School Library).
18 ORG. FOR ECON. CO-OPERATION & DEV. [ OECD], AGRICULTURAL POLICIES IN OECD
COUNTRIES 4 (2009), available at http://www.oecd.org/dataoecd/37/16/43239979.pdf.
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In 1970, powerful states pledged to give 0.7% of their Gross National
Income (GNI) per annum to Official Development Assistance.19  The dead-
line for reaching that target was the mid-1970s, and by 2015 (the target date
for the achievement of the Millennium Development Goals  (MDGs)) the
pledge will be forty-five years old.20  Rich states have renewed the pledge
over the years; for example, in 2005, the Group of Eight (G8) countries
promised a $25 billion annual increase in development assistance for Africa
by 2010, driven by the European Union’s pledge to raise members’ aid
spending for poverty reduction to the target of 0.7% by 2015.21  The routine
reiteration of the 0.7% commitment suggests it is rising to the level of an
agreed international norm.
Even factoring in new investments (for example, disaster relief and the
U.S. President’s Emergency Plan for AIDS Relief), the Organisation for Eco-
nomic Co-operation and Development (OECD) countries have not come
close to fulfilling their pledges.  Their real contribution has only recently
risen to a high of 0.33%.22  The developed world has similarly fallen short in
supporting the MDGs and the Global Fund to Fight AIDS, Tuberculosis, and
Malaria.23  To close the vast investment gap, OECD countries would have to
increase Global Fund pledges from $6 billion to $38 billion by 2015.24  And
they would need to spend an additional $52.4 billion to reduce child mortal-
ity as promised in the MDGs.25  With these additional expenditures, the
WHO projects that millions of lives would be saved every year.26
In general, the global health governance system must reach agreement
on both the funding levels needed to achieve key priorities and the responsi-
bility of rich states to provide this funding.  Figuring out innovative ways to
19 International Development Strategy for the Second United Nations Development Dec-
ade, G.A. Res. 2626 (XXV), ¶ 43, U.N. Doc. A/8214 and Add. 1 (Oct. 24, 1970) (“Each
economically advanced country will progressively increase its official development assistance
to the developing countries and will exert its best efforts to reach a minimum net amount of 0.7
per cent of its gross national product at market prices by the middle of the Decade.”).
20 See Anup Shah, US and Foreign Aid Assistance, GLOBAL ISSUES, Apr. 13, 2009, http://
www.globalissues.org/article/35/us-and-foreign-aid-assistance (on file with the Harvard Law
School Library).
21 See Ronald Labonte & Ted Schrecker, Foreign Policy Matters: A Normative View of the
G8 and Population Health, 85 BULL. WHO 185, 186 (2007), available at http://www.who.int/
entity/bulletin/volumes/85/3/06-037242.pdf.
22 See ONE CAMPAIGN, THE DATA REPORT 2009, at 88 (2009), available at http://
www.one.org/international/datareport2009/pdfs/DR2009.pdf.
23 See UN MILLENNIUM PROJECT, INVESTING IN DEVELOPMENT 55–65 (2005), available at
http://www.unmillenniumproject.org/documents/overviewEngLowRes.pdf.
24 COMM’N ON MACROECON. & HEALTH, WHO, MACROECONOMICS AND HEALTH: INVEST-
ING IN HEALTH FOR ECONOMIC DEVELOPMENT 21 (2001) (arguing international assistance
should increase from current annual level of $6 billion to $27 billion by 2007 and $38 billion
by 2015).
25 Karin Stenberg et al., A Financial Road Map to Scaling Up Essential Child Health
Interventions in 75 Countries, 85 BULL. WHO 305, 305 (2007), available at http://www.who.
int/bulletin/volumes/85/4/06-032052.pdf (stating that an additional $52.4 billion is required for
2006–2015 to reach MDGs in child mortality).
26 See Labonte & Schrecker, supra note 21, at 186.
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ensure adequate and enduring levels of support for agreed-upon priorities
will be vital in ensuring that poor countries gain the capacity to deal with
both everyday health threats and public health emergencies.
In addition to inadequate funding levels, another key global health gov-
ernance problem is the absence of an agreed-upon mechanism to collect,
distribute, and prioritize foreign health assistance.  Each country has unfet-
tered discretion to contribute the amount it wants, to whomever it wants, and
for whatever purpose it wants.  As a result, the level of assistance is unpre-
dictable and not scaled to real needs—that is, funding does not match the
burden of diseases in recipient countries or reflect country priorities, and the
activities supported do not address the fundamental determinants of ill
health.  This leads to chronic problems in international health that perpetu-
ate, or even exacerbate, health inequalities.  Without assured funding
streams, low- and middle-income countries cannot develop and sustain ef-
fective health services for their populations.
The Plan’s Financing Mechanisms
To achieve the objective of sustainable funding, the Global Plan for
Justice would set achievable targets for states to contribute annually to the
new Global Health Fund according to their ability to pay.  Although the
exact levels would be subject to negotiation under WHO auspices, a realistic
figure could be 0.25% of GNI per annum.  This contribution would be in the
form of unrestricted official development assistance, and its calculation
would not include private donations or capital flows and investments.27
In addition to setting targets for state contributions to the Global Health
Fund, the Global Plan for Justice would call on states to continue their cur-
rent development assistance devoted to health programs of their choice.  The
resulting total percentage of GNI dedicated to international development as-
sistance for health, taking into account both contributions to the Global
Health Fund and discretionary funds, would be equivalent at minimum to the
1970 pledge of 0.7% of GNI per annum.  This level of funding would guar-
antee considerable resources for the three principal focal areas of the Global
Plan for Justice—essential medicines, basic needs, and climate change adap-
tations—while still committing states to meet the overall target established
more than thirty-five years ago.  The combined funding level would be a
testament to the priority that governments put on poverty reduction and im-
proved health.
The Global Health Fund would also provide more predictable funding
scaled to real needs.  There is already a disease-specific fund dedicated to
collecting and dispersing international health assistance—the Global Fund to
27 See G.A. Res. 2626 (XXV), supra note 19, ¶¶ 45–47 (“Financial aid will, in principle,
be untied.”).
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Fight AIDS, Tuberculosis, and Malaria.28  But that fund is far too narrow in
scope to meet the basic survival needs that are the focus of the Global Plan
for Justice.  Consequently, the Global Plan for Justice would create a dedi-
cated Global Health Fund and would have the authority to collect resources
from nations according to their ability to pay and the authority distribute
these funds according to need.  Gorik Ooms and his colleagues have pro-
posed a similar fund, which they argue must be tied to a suitable governance
structure like the one proposed here.29  The Global Fund to Fight AIDS, Tu-
berculosis and Malaria demonstrates that such a fund can be developed
through voluntary collective action.  But it must have a broader mandate and
agreed-upon funding levels if it is to address the key determinants of health.
III. PRIORITY SETTING: FROM HIGH-PROFILE CAUSES TO PROGRAMS
THAT WORK30
Currently, international development assistance for health is ineffective.
It is often driven by emotional, high visibility events, such as large-scale
natural disasters; diseases that capture the public’s imagination, such as HIV/
AIDS; or diseases with the potential for rapid global transmission, such as
SARS.  These funding streams skew priorities and divert resources away
from efforts to build stable local health systems to meet everyday needs.
Furthermore, a relatively small number of wealthy donors currently
wield considerable influence in setting the global health agenda.  These in-
clude OECD countries, the Gates Foundation, and the Global Fund to Fight
AIDS, Tuberculosis and Malaria.  Although well-meaning, this small group
of wealthy donors often sets priorities that do not reflect local needs and
preferences.  Donors often fund politically popular projects rather than those
most likely to improve global health.  For example, the United States de-
votes nearly seventy percent of its global health budget to AIDS, with much
of the rest going to countries of geostrategic importance like Afghanistan,
Iraq, Israel, and Pakistan.31  Donors also tend to concentrate on specific dis-
eases or narrow self-interests instead of larger, systemic problems that cause
failing health systems and exacerbate all diseases.  This focus on disease-
specific programs (also called “vertical” programs) can divert resources
28 Global Fund to Fight AIDS, Tuberculosis, and Malaria, About Us, http://
www.theglobalfund.org/en/about/ (on file with the Harvard Law School Library).
29 See generally Gorik Ooms & Rachel Hammonds, Correcting Globalization in Health:
Transnational Entitlements Versus the Ethical Imperative of Reducing Aid-Dependency, 1 PUB.
HEALTH ETHICS 154 (2008).
30 Editor’s Note: The following section represents a synthesis of several of Professor
Gostin’s earlier writings on the global health gap, presented here in relation to his proposal for
the Global Plan for Justice. See generally Gostin, supra note 4;  Lawrence O. Gostin,
Foreword,  Socioeconomic Disparities in Health: A Symposium on the Relationships Between
Poverty and Health, 15 GEO. J. ON POVERTY L. & POL’Y 571 (2008); Lindsay Wiley &
Lawrence O. Gostin, The International Response to Climate Change, 302 JAMA 1218 (2009).
31 George J. Schieber et al., Financing Global Health: Mission Unaccomplished, 26
HEALTH AFF. 921, 927 (2007).
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from systemic (“horizontal”) approaches that build health system capacity
and meet basic survival needs.32
The Global Plan for Justice would follow those scholars and advocates
who have urged for a “human security” approach to health, “a truly univer-
sal package of guaranteed benefits or entitlements, comprising [a] set of
essential services applied to all in the world.”33  In particular, the Plan would
prioritize three core obligations needed to achieve human security, espe-
cially for those suffering from compounding disadvantages: access to essen-
tial vaccines and medicines;  satisfaction of basic survival needs (including
food, water, sanitation, and vector controls); and the ability to respond to the
effects of climate change.
A. Essential Vaccines and Medicines
All people need access to essential vaccines and medicines to achieve
and maintain high levels of health.  To be maximally effective and fair, ac-
cess must address both ongoing needs and urgent needs during public health
emergencies, such as the H1N1 pandemic.
Chronic Needs
According to the WHO, essential vaccines and medicines “are those
that satisfy the priority health care needs of the population.”34  They are
selected for their impact on the public’s health “with due regard to disease
prevalence,” based on evidence of comparative cost effectiveness.35  Using
these criteria, the WHO has developed a Model List of essential medicines,
which countries use as a guide to develop their own specific lists that meet
their national requirements.36  However, despite the relatively widespread
adoption of essential medicine lists, the dream of universal access to essen-
tial vaccines and medicines has not been attained, undermining the health-
related Millennium Development Goals (MDGs) for children, women, and
persons living with AIDS.
Preventative vaccination is one proven cost-effective means by which
to reduce the burden of disease.  Bill Gates has described the halving of
childhood deaths over five decades due to vaccinations as “one of the most
32 See generally Phusit Prakongsai et al., Can Earmarking Mobilize and Sustain Resources
to the Health Sector?, 86 BULL. WHO 898 (2008), available at http://www.who.int/entity/
bulletin/volumes/86/11/07-049593.pdf.
33 Julio Frenk, Strengthening Health Systems to Promote Security, 373 LANCET 2181,
2181 (2009).
34 WHO, Essential Medicines, http://www.who.int/medicines/services/essmedicines_def/
en/index.html (on file with the Harvard Law School Library).
35 Id.
36 Id.
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amazing statistics ever.”37  As researcher Kate Taylor and her colleagues
state: “It is better to prevent disease than to allow avoidable human suffer-
ing, incur the costs of care and treatment, and suffer the economic conse-
quences of lost work and lower productivity.”38
Many vaccines are most effective when administered during childhood,
that is, before potential exposure to disease.  Although childhood immuniza-
tion is at an all-time high,39 two and a half million individuals of all ages die
each year from vaccine-preventable diseases including diphtheria, tetanus,
pertussis (whooping cough), and measles.40  An additional $1 billion per
year invested towards immunization would minimize these preventable
deaths by vaccinating more than seventy million children in the seventy-two
poorest countries.41  In an effort to achieve two-thirds reduction of childhood
mortality by 2015, in line with the MDGs, UNICEF’s Global Immunization
Vision and Strategy calls for a rise in global vaccination coverage for com-
mon preventable childhood diseases, with a goal of at least ninety percent
coverage in every country over the next five years.42  The Strategy estab-
lishes four target areas: immunizing more people, introducing new vaccines
and technologies, integrating immunization to other health interventions and
surveillance within the health system, and managing immunization in the
context of global interdependence.43
Children are not the only population to suffer from preventable deaths.
Poor women are also disproportionately affected by the lack of access to
essential vaccines.  While approximately seventy percent of cervical cancers
are preventable through human papillomavirus vaccines and cervical cancer
screenings, every year cervical cancer affects nearly five hundred thousand
women and causes over a quarter of a million deaths, eighty percent of
which occur in developing countries.44  Developing counties are dispropor-
tionately burdened by this disease in part because of the lack of access to
screenings and vaccinations in these countries.45
In addition to vaccinations, other essential medicines can work success-
fully as inexpensive biological interventions for many conditions.  However,
37 BILL GATES, BILL & MELINDA GATES FOUND., 2009 ANNUAL LETTER FROM BILL GATES
4 (2009), available at http://www.gatesfoundation.org/annual-letter/Documents/2009-bill-
gates-annual-letter.pdf.
38 Kate Taylor et al., The Need for New Vaccines, 27 VACCINE (SUPP. 6) G3, G3 (2009),
available at http://www.ghstrat.com/vaccine121609.pdf.
39 WHO & UNICEF, GLOBAL IMMUNIZATION DATA 1 (2009), available at http://
www.who.int/immunization/newsroom/GID_english.pdf.
40 Id.
41 Lara J. Wolfson et al., Estimating the Costs of Achieving the WHO-UNICEF Global
Immunization Vision and Strategy, 2006–2015, 86 BULL. WHO 27, 35 (2008), available at
http://www.who.int/bulletin/volumes/86/1/07-045096.pdf.
42 UNICEF, The Global Immunization Vision and Strategy (GIVS), http://www.unicef.
org/immunization/index_27089.html (on file with the Harvard Law School Library).
43 Id.
44 WHO & INSTITUT CATALA` D’ONCOLOGIA, HUMAN PAPILLOMAVIRUS AND RELATED
CANCERS 6 tbl.3, 12 tbl.7 (2010), available at http://apps.who.int/hpvcentre/statistics/dynamic/
ico/country_pdf/CUB.pdf.
45 See id. at 44 fig.34, 45 fig.35.
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certain highly publicized diseases have received a disproportionate amount
of public and private attention, pushing other more widespread or inexpen-
sively treatable conditions out of the realm of public discussion.  For exam-
ple, the movement to increase access to antiretroviral (ARV) medications for
AIDS has properly rallied intergovernmental organizations, governments,
and activists, thus reducing AIDS-related deaths by over ten percent in the
past five years.46  These efforts have made ARVs more accessible to AIDS
patients in developing countries by reducing the cost of treatments from
thousands to hundreds of dollars annually.47  Unfortunately, ARVs must be
taken daily and for a lifetime, rendering them a still costly intervention.  And
with the rise in drug-resistant forms of HIV infection and the vastly in-
creased costs of them, the cost of widespread antiretroviral treatment is
likely to rise even higher.
In contrast, intestinal worms and other bacterial infections can be
treated in a short duration for a relatively low sum.  For example,
onchocerciasis, also known as river blindness, is a major cause of blindness
and skin disease in many African countries.  This condition is highly treata-
ble, however, as demonstrated by the WHO’s African Programme for
Onchocerciasis Control.48  By promoting and facilitating the successful dis-
tribution of ivermectin (also known under the brand name Mectizan), the
program effectively decreased the number of onchocerciasis cases from 41.8
million in 1995 to 25.7 million in 2008.49  Mectizan is a single dose, annual
treatment that costs only a couple of dollars.50
Similarly, trachoma, an infectious eye disease that can result in blind-
ness after prolonged exposure to infection, can be treated with antibiotics
and a simple surgical procedure costing less than ten dollars.51  In order to
help minimize global blindness—three percent of which is caused by tra-
choma—the WHO is currently working to develop the Alliance for Global
Elimination of Trachoma by 2020.52  The Alliance will implement methods
based on the WHO’s “SAFE” strategy—surgery, antibiotics, facial cleanli-
ness, and environmental improvement.
46 See WHO & JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS [ UNAIDS],  AIDS
EPIDEMIC UPDATE 8 (2009), available at http://data.unaids.org/pub/Report/2009/JC1700_Epi_
Update_2009_en.pdf.
47 See WHO, UNAIDS & UNICEF, TOWARDS UNIVERSAL ACCESS: SCALING UP PRIORITY
HIV/AIDS INTERVENTIONS IN THE HEALTH SECTOR 74 (2009), available at http://
www.who.int/hiv/pub/tuapr_2009_en.pdf.
48 See WHO, African Programme for Onchocerciasis Control, http://www.who.int/apoc/
en/ (on file with the Harvard Law School Library).
49 See WHO, African Programme for Onchocerciasis Control: About Us, http://
www.who.int/apoc/about/en/index.html (on file with the Harvard Law School Library).
50 See id.
51 Rob M. P. M. Baltussen et al., Cost-Effectiveness of Trachoma Control in Seven World
Regions, 12 OPHTHALMIC EPIDEMIOLOGY 91, 100 (2005).
52 WHO, Trachoma, http://www.who.int/blindness/causes/trachoma/en/index.html (on file
with the Harvard Law School Library).
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These illustrations represent the classic case for increasing access to
essential medicines in poor countries by demonstrating that low-cost treat-
ments can be highly effective in reducing the burden of disease.
Health Impact
There are several factors that contribute to the lack of availability of
essential vaccines and medicines in poor populations.  At present, less than
ten percent of the world’s biomedical research funds are dedicated to ad-
dressing the problems responsible for ninety percent of the world’s disease
burden.  This so-called 90/10 divide exists because developing countries
bear the greatest disease burden but do not offer sufficiently lucrative mar-
kets to encourage pharmaceutical and biotechnology companies to invest in
curing the diseases of poverty.  “The development of drugs is so skewed
towards the needs of rich countries that only 1% of new treatments—just 16
drugs—developed over the past 25 years were for diseases . . . found mainly
in the developing world.”53
The current intellectual property right regime exacerbates this disincen-
tive.  The issuance of patents often allows companies to charge monopoly
prices that developing countries cannot afford, and rich states have actively
pursued increasingly restrictive intellectual property rules through multilat-
eral treaties such as the Trade-Related Aspects of Intellectual Property
Rights agreement (TRIPS) and bilateral agreements such as TRIPS Plus.54
As a result, private drug companies have little incentive to invest in research
that will reduce the disease burden in poor countries.
Barriers exist even to the treatments of diseases that have been deemed
worthwhile research investments, such as AIDS, because monopoly prices
(albeit often discounted or donated) impede developing countries’ access to
these treatments.  In the case of AIDS, the drastic decrease in costs of ARVs
over a short period of time, as mentioned above, was facilitated by the lack
of patent protection in certain countries such as Brazil and India that had the
capacity to manufacture the drugs.55  These countries were thus able to mass
manufacture generic versions of ARVs, producing a competitive market that
resulted in reduced prices.56
Overall, the combination of private industry incentives, intellectual
property hurdles, and the 90/10 divide works to obstruct poor populations’
53 Nathan Ford, Medecins Sans Frontiers, The 90/10 Divide (Aug. 1, 2002), http://www.
msf.org/msfinternational/invoke.cfm?component=article&method=full_html&objectid=7A
67B622-4CCB-4612-AC59B95227BF0E45 (on file with the Harvard Law School Library).
54 See Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15, 1994,
Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, 108 Stat. 4809,
869 U.N.T.S. 299, available at http://www.wto.org/english/docs_e/legal_e/27-trips.pdf.
55 See Campaign for Access to Essential Meds., The Impact of Patents on Access to
Medicines, http://www.msfaccess.org/main/access-patents/introduction-to-access-and-patents/
the-impact-of-patents-on-access-to-medicines/ (on file with the Harvard Law School Library).
56 See id.
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access to essential medicines despite the existence of inexpensive methods
to effectively minimize the burden of disease.
Public Health Emergencies
Public health emergencies such as the H1N1 (swine flu) pandemic, the
Samoan tsunami, and the Sumatran and Haitian earthquakes underscore the
immediate and crucial need for fair allocation of vaccines and medicines.
Mass disasters almost inevitably lead to a surge in demand that causes a
scarcity of medicines.  In the face of such scarcities, poor countries tend to
be left behind.  If the threat is a novel one, such as an emerging infectious
disease, treatments must be discovered, tested, produced, and delivered in a
much narrower time frame than usual.  In order to assure this rapid roll-out,
governments will often have to fund the necessary research, development,
and deployment, which poor countries will not be able to afford.  The phar-
maceutical industry is also likely to supply markets that can afford to pay
and countries where they are located.  In addition, more than ninety percent
of the world’s capacity to manufacture some vaccines is concentrated in Aus-
tralia, Europe, and North America.57  During mass disasters, governments
face intense pressure to protect their own citizens, making rich countries
likely to hoard the vaccines and medicines they produce and purchase rather
than sharing their supplies with poor countries.  All of these factors leave
poor countries in Africa, Asia, and Latin America much more vulnerable to
public health emergencies.
The global response to the H1N1 pandemic is a case in point.  The U.S.
Congress has authorized $7.65 billion in H1N1-related spending, with the
vast majority for therapeutic interventions such as vaccine development and
distribution and stockpiling of the antiviral Tamiflu.58  Health and Human
Services Secretary Kathleen Sebelius requested full funding for a drive to
vaccinate all Americans if necessary.59  This is on top of the greater than $7
billion dollar federal authorization for Influenza A (H5N1 or avian influ-
enza).60  Public and private spending on influenza treatments has resulted in
a windfall for the pharmaceutical industry, with Roche reporting that sales of
Tamiflu tripled and GlaxoSmithKline predicting huge profits from a
vaccine.61
57 Lawrence O. Gostin, Pandemic Influenza: Public Health Preparedness for the Next
Global Health Emergency, 32 J.L. MED. & ETHICS 565, 569 (2004).
58 Mitchel L. Zoler, U.S. Government Pays the H1N1 Vaccination Bill, THELANCET.COM,
Oct. 12, 2009, http://www.thelancet.com/H1N1-flu/egmn/0c03bfca (on file with the Harvard
Law School Library).
59 See News Release, U.S. Dep’t of Health & Human Servs., Obama Administration Calls
on Nation to Begin Planning and Preparing for Fall Flu Season & the New H1N1 Virus (July 9,
2009), available at http://www.hhs.gov/news/press/2009pres/07/20090709a.html.
60 See generally Lawrence O. Gostin & Benjamin E. Berkman, Pandemic Influenza: Eth-
ics, Law, and the Public’s Health, 59 ADMIN. L. REV. 121 (2007).
61 Andrew Pollack, Sales of Flu Drug Improve Results at Roche, N.Y. TIMES, July 24,
2009, at B3.
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Despite the vast sums spent on these novel strains of influenza, very
little will go to benefit low- and middle-income countries.  In October 2009,
when the first doses of H1N1 vaccine became available in the United
States,62 the WHO estimated worldwide production capacity to be “about 3
billion doses per year in 12 months if all available capacity is devoted to
pandemic vaccine.”63  Although the WHO called for efforts to ensure equita-
ble access to the H1N1 vaccine for low- and middle-income countries, fund-
ing was secured for only around two hundred million doses.64  Originally,
the United States pledged, along with ten other countries, to donate ten per-
cent of its vaccine doses to developing countries, even though it had yet to
meet its own vaccine demands.65  However, with more severe vaccine
shortages than anticipated, the Department of Health and Human Services
chose to reevaluate its initial commitment.  “It has always been the
[P]resident’s intention,” Secretary Sebelius stated, “that the safety and se-
curity of the American people be a priority in the production and distribu-
tion.”66  Accordingly, only a minuscule $350 million of H1N1 resources in
the United States are being spent for global health and child survival, and
two-thirds of that sum will go to surveillance, which benefits rich countries
more than the poor.67
To put all this in perspective, although the United States may ultimately
donate leftover doses to developing countries,68 its response to the first phase
of the H1N1 pandemic shortage presents a clear example of a wealthy coun-
try prioritizing its own citizens at the expense of poorer countries during a
public health emergency.  As of early 2010, well after populations were im-
munized in the developed world, the WHO still had very little vaccine to
distribute to the poor.
The WHO has stated that the pandemic is declining, but with confirmed
deaths estimated at over twelve thousand worldwide, the current inequitable
62 See Ctrs. for Disease Control & Prevention, Questions & Answers: Vaccine Against
2009 H1N1 Influenza Virus, http://www.cdc.gov/h1n1flu/vaccination/public/vaccina-
tion_qa_pub.htm (on file with the Harvard Law School Library).
63 WHO, Production and Availability of Pandemic (H1N1) 2009 Vaccines, http://
www.who.int/csr/disease/swineflu/frequently_asked_questions/vaccine_preparedness/produc-
tion_availability/en/index.html (on file with the Harvard Law School Library).
64 See id. (“WHO’s goal is to provide each of these 95 countries with enough vaccine to
immunize at least 10% of its population.”).
65 See Chris Neefus, Sebelius Says U.S. Will Donate Part of H1N1 Vaccine Supply to
Foreign Nations Before Meeting This Nation’s Demand, CNSNEWS.COM, Oct. 22, 2009, http://
www.cnsnews.com/news/article/55907 (on file with the Harvard Law School Library).
66 Penny Starr, Sebelius: Feds Knew H1N1 Vaccine Supply Was Not Enough to Cover At-
Risk Americans, CNSNEWS.COM, Oct. 29, 2009, http://www.cnsnews.com/news/article/56269
(on file with the Harvard Law School Library).
67 See Supplemental Appropriations Act 2009, Pub. L. No. 111-32, § 701, 123 Stat 1859,
1884–85.
68 See More H1N1 Vaccine Has U.S. Urging Shots for All, ASSOCIATED PRESS, Dec. 17,
2009, http://www.msnbc.msn.com/id/34465289 (on file with the Harvard Law School
Library).
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distribution of H1N1 vaccines remains an important concern.69  If the pan-
demic is sustained, those who suffer from compounding disadvantages, such
as the dual burden of infectious and chronic disease, will suffer most.  At the
same time, if the virus mutates or genetically combines with the avian influ-
enza virus, it could become far more pathogenic.
Serious questions of global social justice arise when wealth, rather than
need, becomes the primary criterion for allocating life-saving therapeutics.
The maldistribution of vaccines in the face of a global health crisis will only
widen the already large health gap between the rich and the poor.  The WHO
defines equity as “[t]he fair distribution of benefits and burdens,” noting
that “in some circumstances, it may be equitable to give preference to those
who are worst off, such as the poorest, the sickest, or the most vulnerable.”70
In the case of mass disasters, justice requires that scarce interventions go to
the most disadvantaged in the world, because they are at the greatest risk of
serious illness and death from a novel infection.  Allocation of resources to
the world’s most vulnerable is likely to have the maximum beneficial effect
on morbidity and premature mortality.71  Equitable access to essential medi-
cal resources is not merely a moral imperative—it is also critically necessary
for the success of any pandemic strategy to safeguard global health given the
rapid international spread of infectious diseases.
B. Basic Survival Needs
While access to essential medicines and vaccines can greatly improve
the life prospects of the poor, such interventions are ultimately limited in
their ability to reduce morbidity and premature mortality.  For example,
medicines and vaccines are only effective against certain diseases.  What is
truly needed, and what richer countries instinctively (although not always
adequately) do for their own citizens, is to meet what I call “basic survival
needs—namely those needs essential to restoring human capability and
functioning.”72  By focusing on the major determinants of health, the inter-
national community could improve global health.
Basic survival needs include sanitation and sewage; pest control; clean
air and water; diet and nutrition; reductions in tobacco use; and well-func-
tioning health systems for the prevention, detection, and mitigation of dis-
ease and premature death.  Basic survival needs are laid out in international
agreements.  Three of the eight MDGs, for example, are health-related: child
mortality, maternal health, and the reduction of the burden of infectious dis-
69 See Stephanie Nebehay, May Take a Year to Conquer H1N1 Flu Pandemic, REUTERS,
Dec. 29, 2009, http://www.reuters.com/article/idUSTRE5BS14B20091229 (on file with the
Harvard Law School Library).
70 WHO, ETHICAL CONSIDERATIONS IN DEVELOPING A PUBLIC HEALTH RESPONSE TO PAN-
DEMIC INFLUENZA, at  v (2007), available at http://www.who.int/csr/resources/publications/
WHO_CDS_EPR_GIP_2007_2c.pdf.
71 Gostin, supra note 57, at 569.
72 Gostin, supra note 4, at 337.
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eases.73  The UN Economic and Social Council finds that basic survival
needs are a core commitment of the right to health, and that they include
access to food, potable water, sanitation, disease prevention and treatment,
primary health care, and health education.74
The following sections illustrate the power of meeting basic human
needs.
Sanitation and Engineering
Basic sanitation and engineering can have a dramatic impact on the
health of the world’s poor.  Many of the diseases of poverty are water-borne
(for example, cholera, diarrhea, guinea worm, and schistosomiasis), mos-
quito-borne (for example, dengue fever, elephantiasis, malaria, and yellow
fever), or rodent-borne (for example, plague, lassa fever, hantavirus, and
leptospirosis).  Wild rodents also serve as reservoirs for flea- or tick-borne
diseases such as typhus, Lyme disease, and relapsing fever.75  These diseases
are preventable through personal hygiene, environmental sanitation, and
structural changes to abate the source of the infection.
Water and sanitation play a pivotal role in sustainable development and
health.  More than a billion people lack access to drinkable water and more
than 2.4 billion lack access to basic sanitation.76  Ensuring clean water
sources, such as potable drinking water and parasite-free lakes and rivers,
can prevent most cases of water-borne diseases.  Simple improved sanitation
measures include the construction of latrines, basic engineering advances to
provide clean drinking water, and disinfestation of standing bodies of water.
Something as simple as piped water could substantially reduce child mortal-
ity, and the simple use of preventive equipment such as household point-of-
use water treatment kits can similarly reduce diarrhea episodes plaguing
children in poor countries.77  Such interventions are highly cost effective and
can significantly reduce the disease burden at nominal expense.  Point-of-use
kits costing only a little over three dollars can treat a thousand liters of
water.78  Other simple approaches that can prevent water-borne diseases in-
73 See generally UNITED NATIONS, MILLENNIUM DEVELOPMENT GOALS REPORT 2009
(2009), available at http://www.un.org/millenniumgoals/pdf/MDG_Report_2009_ENG.pdf.
74 See U.N. Comm. on Econ., Soc. & Cultural Rights, General Comment 14: The Right to
the Highest Attainable Standard of Health, U.N. Doc. E/C.12/2000/4 (2000), available at
http://www.unhcr.org/refworld/docid/4538838d0.html.
75 See, e.g., HANS ZINSSER, RATS, LICE AND HISTORY: A BACTERIOLOGIST’S CLASSIC HIS-
TORY OF MANKIND’S EPIC STRUGGLE TO CONQUER THE SCOURGE OF TYPHUS (1934).
76 See U.N. DEV. PROGRAMME, THE HUMAN DEVELOPMENT REPORT 2006, at 2 (2006),
available at hdr.undp.org/en/media/HDR06-complete.pdf.
77 See Alix Peterson Zwane & Michael Kremer, What Works in Fighting Diarrheal Dis-
eases in Developing Countries? A Critical Review 4 (Ctr. for Int’l Dev. at Harvard Univ.,
Working Paper No. 140, 2007), available at http://www.cid.harvard.edu/cidwp/pdf/140.pdf.
78 See Pavani Kalluri Ram et al., Bringing Safe Water to Remote Populations: An Evalua-
tion of a Portable Point-of-Use Intervention in Rural Madagascar, 97 AM. J. PUB. HEALTH
398, 398 (2007).
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clude drilling wells, treating local water sources with a mild pesticide, or
filtering drinking water with a cloth to remove guinea worms.79
Mosquito-borne diseases are more resistant to amelioration, but cost-
effective interventions exist to prevent them by reducing the mosquito popu-
lation and human exposure.  An insecticide-treated bednet, which costs
roughly five dollars and provides protection for up to five years, is highly
effective in reducing malaria, river blindness, elephantiasis, and other insect-
borne diseases among children.80  But only about one in seven children in
Africa sleep under a net, and only three percent of children use an insecti-
cide-treated net.81  Structurally, using insecticides and reducing larval breed-
ing sources can also be effective.  Dicophane (DDT) has “a remarkable
safety record when used in small quantities for indoor spraying in endemic
regions.”82  Yet many donor agencies refuse to fund its use.83  First world
environmental concerns are preventing a highly effective intervention for the
world’s poor.
Rodent-borne diseases are also resistant to amelioration, but the burden
of disease can be significantly reduced by sanitation and disinfestations.  Im-
proving human hygiene and environmental sanitation can deprive rodents of
food, living spaces, and passage into inhabited areas.  The use of poisons,
bait, and traps can also reduce rodent populations.
Basic engineering and sanitation can result in remarkable benefits for
the health of the world’s poorest people.  Advanced biomedical research,
huge financial investments, and complex programs are not the only options.
As I have previously written: “Just as industrialized countries profoundly
reduced the prevalence of disease during the late nineteenth century through
sanitary measures applied to water, food, pests, and the environment, so too
can this be accomplished at relatively low cost in the world’s poorest
regions.”84
Health Systems: Infrastructure and Capacity Building
There is little doubt that the single most effective way to ensure popula-
tion health would be to build enduring health systems in all countries.  States
79 See Donald G. McNeil, Jr., Dose of Tenacity Wears Down an Ancient Horror, N.Y.
TIMES, Mar. 26, 2006, § 1, at 1.
80 See David H. Molyneux & Vinand M. Nantulya, Linking Disease Control Programmes
in Rural Africa: A Pro-Poor Strategy to Reach Abuja Targets and Millennium Development
Goals, 328 BRIT. MED. J. 1129 (2004).
81 See WHO & UNICEF, AFRICA MALARIA REPORT 2003, at 26 (2003), available at http:/
/www.rollbackmalaria.org/amd2003/amr2003/pdf/amr2003.pdf; John M. Miller et al., Estimat-
ing the Number of Insecticide-Treated Nets Required by African Households to Reach Conti-
nent-wide Malaria Coverage Targets, 297 JAMA 2241, 2243–44 (2007).
82 Gavin Yamey, Roll Back Malaria: A Failing Global Health Campaign, 328 BRIT. MED.
J. 1086, 1087 (2004).
83 Roger Bate & Kathryn Boateng, Honesty Is a Virtue, in Foreign Affairs, How to Pro-
mote Global Health: A Foreign Affairs Roundtable, Jan. 24, 2007, http://www.foreign
affairs.org/special/global_health/ (on file with the Harvard Law School Library).
84 Gostin, supra note 4, at 371.
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and local communities must possess well-functioning public health systems
with sound infrastructures and adequate human resources.  If more interna-
tional assistance went into helping poor states develop and maintain health
systems, these states might become capable of safeguarding their own popu-
lations, rather than remaining dependent on foreign assistance.  Poor coun-
tries do not need foreign aid workers to parachute in and rescue their people
from specific diseases that seem important to donors.  Nor do they need
foreign-run, state-of-the-art facilities.  Rather, they need to gain the capacity
to provide basic health services for themselves.  Health system capacity has
the added benefit of improving global health by significantly reducing the
potential for disease migration to other countries and regions.  Local capaci-
ties empower health professionals to prevent, rapidly detect, treat, and con-
tain health hazards before they spread out of control.85
Governments possess a primary duty to safeguard their populations
against significant health hazards.86  Public health agencies, in collaboration
with civil society partners (for example, businesses, the community, and the
media), have a responsibility to create the conditions for people to be
healthy.87  Their role is to identify, prevent, and ameliorate risks to health in
the population.  To do so, poor countries do not need advanced technology
or sophisticated equipment.  Rather, they require basic capabilities: disease
surveillance tools, laboratories, health information data systems, and a com-
petent workforce.  There are multiple inexpensive public health functions
that are vital for a healthy community, such as health education, hygiene and
sanitation, uncontaminated food and drinking water, pest removal, and ac-
cess to immunizations and essential medicines.  By training and supporting
epidemiologists, biostatisticians, health educators, and public health nurses,
poor countries can find sustainable solutions to their own problems.
An integral part of a country’s health system is basic primary health
care that is as close as possible to where people live and work.  The WHO
Alma-Ata Declaration defined primary health care as “essential health care
based on practical, scientifically sound and socially acceptable methods and
technology made universally accessible [and affordable] to individuals and
families in the community . . . at every stage of their development in the
spirit of self-reliance and self-determination.”88  In 2008, on the thirtieth an-
niversary of Alma-Ata, as globalization placed social cohesion under stress
and health systems continued to underperform, the World Health Report
called for a renewal of public health care.89  Director General Margaret Chan
85 See generally WHO, THE WORLD HEALTH REPORT 2000: HEALTH SYSTEMS: IMPROVING
PERFORMANCE (2000), available at http://www.who.int/whr/2000/en/whr00_en.pdf.
86 See LAWRENCE O. GOSTIN, PUBLIC HEALTH LAW: POWER, DUTY, RESTRAINT 5 (2008).
87 See INST. OF MED. OF THE NAT’L ACADS., THE FUTURE OF THE PUBLIC’S HEALTH IN THE
21ST CENTURY 17 (2002), available at http://books.nap.edu/openbook.php?record_id=10548.
88 Int’l Conference on Primary Health Care, Declaration of Alma-Ata § 6, Alma-Ata,
USSR (Sept. 6–12, 1978), available at http://www.who.int/hpr/NPH/docs/declaration_almaata.
pdf.
89 WHO, WORLD HEALTH REPORT 2008: PRIMARY HEALTH CARE NOW MORE THAN EVER,
at xi (2008), available at http://www.who.int/whr/2008/whr08_en.pdf.
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asked political leaders to “pay close attention to rising social expectations
for health care—care that is fair as well as efficient,” and to renew their
commitment to emphasizing “local ownership . . . that honour[s] the resili-
ence and ingenuity of the human spirit and makes space for solutions that are
created by communities, owned by them, and sustained by them.”90
The components of primary health care include counseling, maternal
and child health, family planning, and medical treatment.  Primary health
care does not require advanced tertiary care centers or even highly special-
ized physicians.  Rather, it requires family doctors, nurses, midwives, and
community health workers to take care of pregnant women, safely deliver
babies, teach people how to live safely, and diagnose and treat the most
common injuries and diseases.  Primary care promotes individual and com-
munity self-reliance and participation in the planning, organization, opera-
tion and control of health services, making the fullest possible use of both
local and national resources.91
Everyday survival needs may lack the glamour of high-technology
medicine, but what they lack in excitement they gain in their potential im-
pact on health.  Well-functioning health systems have the potential to deal
with the major causes of common disease and disabilities across the world.
C. Adaptation to Climate Change
A scientific consensus exists that climate change is caused by human
activity and has a negative impact on human health, particularly for the
poor.92  Although these inequitable effects are increasingly understood, inter-
national climate change negotiations are still focused more on environmental
degradation and species reductions than on human health.  In the interests of
global justice, the international community should not only seek to reduce
further climate change, but should implement strategies for adaptation by
those who will be most affected.
The numerous direct and indirect linkages between climate change and
human health can be divided into four categories: extreme events, water and
food supply, climate-sensitive diseases, and air quality.  First, evidence
shows that climate change causes increasingly intense and frequent natural
disasters such as tropical storms, floods, heat waves, droughts, and wildfires,
which will result in injury, disease, and mass evacuations to unsanitary shel-
ters.93  Although the causal relationship between climate change and particu-
90 Margaret Chan, Return to Alma-Ata, 372 LANCET 865, 865–66 (2008).
91 See PAN AM. HEALTH ORG., WHO, RENEWING PRIMARY HEALTH CARE IN THE AMERI-
CAS 15–16 (2007), available at http://www.paho.org/English/AD/THS/primaryHealthCare.pdf.
92 See generally W. Neil Adger et al., Assessment of Adaptation Practices, Options, Con-
straints and Capacity, in CLIMATE CHANGE 2007: IMPACTS, ADAPTATION AND VULNERABILITY
717 (M. L. Parry et al. eds., 2007), available at http://www.ipcc.ch/publications_and_data/ar4/
wg2/en/contents.html (examining the challenges of adaptation to climate change among
humans and ecological systems).
93 Ulisses Confalonieri et al., Human Health, in CLIMATE CHANGE 2007, supra note 92, at
391, 394.
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lar disasters is difficult to establish,94 the heat wave in Europe (2003), the
flooding in Mumbai (2005), and Hurricane Katrina in the United States
(2005) are illustrative of events that are likely to occur more often in the
future.  More people will die from natural disasters, especially in areas of the
world that lack the physical and institutional infrastructure to prevent and
treat mass casualties.95  Indirectly, these events will also result in the con-
tamination of surface water and drinking water, causing gastrointestinal ill-
ness and leading to an increase in trauma and stress-related mental illness.96
Second, climate change is particularly devastating for human health be-
cause it drastically reduces the supply of clean water needed for drinking,
sanitation, and crop irrigation.  Climate change is also expected to play a
major role in putting much of Africa under severe water stress as soon as
2020.97  “The impacts . . . on freshwater systems and their management are
mainly due to the observed and projected increases in temperature, sea level
and precipitation variability.”98  Scarcity in sanitary water sources will dra-
matically increase diarrheal illnesses.  According to the WHO, by “2030 the
estimated risk of diarrhea will be up to ten percent higher in some regions
than if no climate change occurred.”99  Ecosystem changes and water scar-
city will also impair crop, livestock, and fisheries yields, leading to in-
creased hunger and a heightened likelihood of famines.100  These cataclysmic
events may result in economic instability, mass migrations, civil unrest, and
armed conflict in a time of competition for increasingly scarce resources.
Third, climate change creates fertile conditions for, and alters the geo-
graphic range of, disease vectors such as mosquitoes, ticks, and rodents,
bringing them into greater contact with human populations that are insuffi-
ciently aware of the diseases they carry.101  Malaria, for example, is expected
to move to higher altitudes,102 and dengue is expected to move farther north
94 See, e.g., WORLD METEOROLOGICAL ORG. INT’L WORKSHOP ON TROPICAL CYCLONES,
STATEMENT ON TROPICAL CYCLONES AND CLIMATE CHANGE ¶ 21 (2006), available at http://
www.wmo.int/pages/prog/arep/tmrp/documents/iwtc_statement.pdf.
95 WHO ET AL., Summary to CLIMATE CHANGE AND HUMAN HEALTH—RISK AND RE-
SPONSES 15 (2003), available at http://whqlibdoc.who.int/publications/2003/9241590815.pdf
(“Developing countries are poorly equipped to deal with weather extremes, even as the popu-
lation concentration increases in high-risk areas like coastal zones and cities. Hence, the num-
ber of people killed, injured or made homeless by natural disasters has been increasing
rapidly.”).
96 Ctrs. for Disease Control & Prevention, Climate Change and Public Health, http://
www.cdc.gov/ClimateChange/effects/extremeweather.htm (on file with the Harvard Law
School Library).
97 INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, CLIMATE CHANGE AND WATER 79
(Bryson Bates et al. eds., 2008), available at http://www.ipcc.ch/pdf/technical-papers/climate-
change-water-en.pdf.
98 Z. W. Kundzewicz et al., Freshwater Resources and Their Management, in CLIMATE
CHANGE 2007, supra note 92, at 175.
99 WHO ET AL., supra note 95, at 19.
100 Confalonieri et al., supra note 93, at 399, 413.
101 Id. at 403.
102 M. Pascual et al., Malaria Resurgence in the East African Highlands, 103 PROC. NAT’L
ACAD. SCI. U.S. 5829, 5829 (2006), available at http://www.pnas.org/content/103/15/
5829.full.pdf.
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and south, increasing the number of people at risk of contracting these dis-
eases.  In the next seventy years, the risk of dengue could become twice as
large as the risk absent any climate change.103  Scientists also anticipate in-
creases in food- and water-borne illness, both of which thrive in warmer
conditions.104
Fourth, climate change affects air quality, particularly in urban environ-
ments, as increased temperatures exacerbate air pollution, especially ground-
level ozone and particulate matter.105  Rising temperatures and higher con-
centrations of CO2 will also increase the concentration of allergenic aeropol-
lens.106  The impact of climate change on air quality will add to the burden of
respiratory and cardiovascular diseases, particularly among the chronically
ill, such as individuals with asthma.107
Although climate change will affect every region of the world, it will
disproportionately burden the global poor and exacerbate global health dis-
parities.  The World Bank estimates that developing countries would bear
75–80% of the costs of climate change.108  Even a 2°C warming above
preindustrial temperatures—the minimum the world is likely to experi-
ence—could result in permanent reductions in GDP of 4–5% for Africa and
South Asia.109  Of the approximately 600,000 deaths that occurred world-
wide as a result of weather-related natural disasters during the 1990s, some
95% of these were in poor countries.  Other research suggests that “climate
change caused a loss of 5.5 million disability-adjusted life years in 2000—
84% of them in Sub-Saharan Africa and East and South Asia.”110  In fact,
disadvantaged populations already live on the edge, with extreme scarcity of
clean water and nutritious food, as well as high rates of endemic and epi-
demic infectious disease.  The world’s poorest people also have the least ca-
pacity to ameliorate the potentially devastating effects of climate change.
They have weak health systems, poor infrastructures, and less technological
and manufacturing capabilities, which undermine their ability to adapt to
rapidly changing weather conditions.  Most are in tropical and subtropical
regions already subject to a highly variable climate.
Health concerns should play a crucial role in climate change negotia-
tions, but thus far, environmental governance structures have largely failed
to include health advocates and policymakers in a coordinated response to
climate change.  The U.S. delegation to the 2009 Copenhagen Summit, for
example, did not include the Health and Human Services Secretary or mem-
103 Confalonieri et al., supra note 93, at 408.
104 Id. at 400.
105 Id. at 401.
106 Id. at 402.
107 Paul John Beggs & Hilary Jane Bambrick, Is the Global Rise of Asthma an Early
Impact of Anthropogenic Climate Change?, 113 ENVTL. HEALTH PERSP. 915, 915–19 (2005).
108 WORLD BANK, WORLD DEVELOPMENT REPORT 2010: DEVELOPMENT AND CLIMATE
CHANGE 5 (2010), available at http://siteresources.worldbank.org/INTWDR2010/Resources/
5287678-1226014527953/WDR10-Full-Text.pdf.
109 Id.
110 WHO, WORLD HEALTH REPORT 2002, at 72 (2002), available at http://www.who.int/
whr/2002/en/whr02_en.pdf; WORLD BANK, supra note 108, at 41.
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bers of the House Committee on Health, Education, Labor, and Pensions.111
In addition, although global health advocates understand the importance of
climate change, they have failed to delve into the potential of environmental
policy as a tool for promoting global health.  This is a critical time for public
health advocates to demand that political leaders safeguard the health of the
world’s population.
The Global Plan’s strategy to address the effects of climate change on
human health is two-pronged.  First, the Plan calls for the incorporation of
land-use and agricultural mitigation, such as avoiding deforestation and deg-
radation and pursuing sustainable agricultural practices.  These efforts not
only reduce the environmental harms that contribute to climate change, they
also increase long-term resilience and provide more immediate collateral
benefits by protecting populations from extreme weather events, reducing
the risk of infectious disease, and improving air, soil, and water quality.112
Second, the Plan advocates for full funding of adaptation projects as a global
priority.  Adaptation programs are aimed at altering natural or human sys-
tems to prepare populations to survive the effects of climate change.  They
include disease surveillance and response, food and water security, and natu-
ral disaster preparedness.  Global health advocates have been urging for pro-
grams like these for decades.
Originally, the international community focused its climate change ef-
forts almost exclusively on mitigation.  However, adaptation-based pro-
grams have become more common.  The crucial question looming in the
aftermath of the UN Copenhagen negotiations is whether the developed
countries’ offer to help the world’s poor to adapt to climate change is suffi-
cient to meet their needs.  The focus of the final draft of the Copenhagen
Accord was on mitigation and emissions reductions.  However, the nonbind-
ing accord also called for developed nations to provide a total of $30 billion
for developing nations over the next two years, which is to be allocated
equally between mitigation and adaptation and prioritized for the most vul-
nerable developing nations.113  The Accord also called for $100 billion in
funding by the year 2020.
Since 2001, the UN Framework Convention on Climate Change has
developed three funds to support adaptation-based programs in developing
nations: the Least Developed Countries Fund, the Adaptation Fund, and the
Special Climate Change Fund.  As of 2009, developed countries had pledged
111 See Press Release, House Speaker Nancy Pelosi, Pelosi Leads Bipartisan Delegation to
Copenhagen (Dec. 16, 2009), available at http://www.speaker.gov/newsroom/press-
releases?id=1478; see also Press Release, The White House, President to Attend Climate
Talks (Nov. 25, 2009), available at http://geneva.usmission.gov/2009/11/25/obama-copenha-
gen/.
112 See David Takacs, Carbon into Gold: Forest Carbon Offsets, Climate Change Adapta-
tion, and International Law, 15 HASTINGS W.-NW. J. ENVTL. L. & POL’Y 39, 43–44 (2009).
113 U.N. Framework Convention on Climate Change, Copenhagen Accord ¶ 8, Draft Deci-
sion -/CP.15 (Dec. 7–18, 2009), available at http://unfccc.int/resource/docs/2009/cop15/eng/
l07.pdf.
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only about $300 million to these funds.114  This amount does not even begin
to meet the mounting needs of the poor as they cope with a changing climate
that could threaten their survival.  In addition to substantially increasing fi-
nancial support for these and other similar funds, the international commu-
nity should also promote adaptation by ensuring that existing development
programs comply with environmental objectives.  Emphasis should be
placed on sustainable development.  Money utilized to meet the needs of
current populations in the developing world should be spent in a way that
will allow future generations, in light of changing environments, to meet
their health and other needs as well.
Climate change will continue to have a profound impact on human
health, especially among the world’s most vulnerable populations.  Leaders
in the developed world should frame climate change as a public health issue.
First, as a matter of global justice, the international community should work
with public health experts to ensure that money is appropriated not only to
mitigate climate change, but also to adapt human systems to ameliorate the
health consequences of climate change in the world’s poorest countries.  This
will entail a significant transfer of wealth, but it is needed to ensure that the
poor are protected against harsh environmental conditions for which they are
not responsible.  Second, by focusing on the harmful effects of climate
change on disease, air quality, and food and water supply, politicians may
have an easier time supporting these programs, especially in countries like
the United States where climate change is still controversial.
Adaptation to climate change, and its integral connection with global
health, is among the defining issues of our time.  If the international commu-
nity does not act boldly, and with a full sense of global justice, the health
gap between rich and poor will only grow larger and more ethically
problematic.
TOWARD A BOLD AND INNOVATIVE GLOBAL COMPACT TO REDUCE THE
UNCONSCIONABLE HEALTH GAP
In this Article, I have sought to demonstrate the unconscionable health
burdens borne by the world’s poorest people and the failure of political will
to close this yawning health gap.  If the international community truly
desires to close the gap, it must find bold and innovative solutions.  Here I
have proposed a Global Plan for Justice—an international compact among
states, industry, philanthropy, and civil society to take immediate and con-
crete steps to pursue global justice.  This international accord would focus
on three of the most fundamental solutions to reduce suffering and early
death: essential vaccines and medicines to treat both for chronic needs and
mass disasters, basic survival needs to ensure the conditions in which all
114 Climatefundsupdate.org, Climate Funds, Dec. 2009, http://www.climatefundsupdate.
org/listing (on file with the Harvard Law School Library).
\\server05\productn\H\HLP\4-2\HLP203.txt unknown Seq: 24 17-JUN-10 12:24
294 Harvard Law & Policy Review [Vol. 4
people can be healthy, and adaptation to the dramatic adverse effects of cli-
mate change.
The Global Plan for Justice should not be difficult to accomplish.  It
requires no international treaty and no cumbersome governance system.
Rather, it relies on the voluntary agreement of the world’s rich countries,
based on a recognition of their ethical obligations to the poor.  Additionally,
it places the responsibility to forge an agreement on the World Health Or-
ganization, which should assume its place as the global health leader.
The Global Plan would not be a panacea, but would genuinely address
the key global health challenges that have thus far thwarted international
efforts to close the health gap.  These challenges—which have been so resis-
tant to change—include the deep fragmentation of actors and programs, the
paucity of resources to meet large needs in a predictable and scalable fash-
ion, and the failure to address the deep underlying determinants of ill health
and early death among the world’s poor.
The uncomfortable truth is that closing the health gap is well within the
means of the international community.  The resources needed are quite small
when compared with existing expenditures on, for example, arms or agricul-
tural subsidies.  We possess the scientific knowledge base about how to dras-
tically reduce health risks through basic sanitation, hygiene, food, water, and
other necessities.  And international health agencies have long championed
the primary importance of building capacity for well-functioning health sys-
tems.  But political communities in wealthy countries still prefer their pet
projects over effective and efficient coordinated action.  They follow poli-
cies that are consistent with their geostrategic interests and the interests of
favored domestic pressure groups, not with the needs of the global poor.
Cooperative action for global health, such as the Global Plan for Jus-
tice, benefits those living with systematic disadvantages, but it also does
much more than that by diminishing our collective vulnerabilities.  The in-
ternational community must do more than lament ongoing, unconscionable
health inequalities.  It must act boldly and with a shared voice.  If we do not,
then the avoidable suffering and early death among the world’s least healthy
people will continue unabated.  That is a breach of social justice that is no
longer ethically acceptable.
